Cattle antibodies identify a cross-serotype broadly neutralising foot-and-mouth disease virus epitope.

Saved in:
Bibliographic Details
Title: Cattle antibodies identify a cross-serotype broadly neutralising foot-and-mouth disease virus epitope.
Authors: Bonnet-Di Placido M; The Pirbright Institute, Pirbright, Surrey, UK., Duyvesteyn HME; Division of Structural Biology, The Henry Wellcome Building for Genomic Medicine, University of Oxford, Headington, Oxford, UK., Steyn AW; The Pirbright Institute, Pirbright, Surrey, UK., Hay AL; The Pirbright Institute, Pirbright, Surrey, UK., Porta C; Division of Structural Biology, The Henry Wellcome Building for Genomic Medicine, University of Oxford, Headington, Oxford, UK., Valdez KR; The Pirbright Institute, Pirbright, Surrey, UK., Lokhman E; The Pirbright Institute, Pirbright, Surrey, UK., Crossley S; The Pirbright Institute, Pirbright, Surrey, UK., Hanson K; The Pirbright Institute, Pirbright, Surrey, UK., Mwangi WN; The Pirbright Institute, Pirbright, Surrey, UK., Munir D; The Pirbright Institute, Pirbright, Surrey, UK., Perez-Martin E; The Pirbright Institute, Pirbright, Surrey, UK., Knowles NJ; The Pirbright Institute, Pirbright, Surrey, UK., Burman A; The Pirbright Institute, Pirbright, Surrey, UK., Yassin AA; The Pirbright Institute, Pirbright, Surrey, UK., Asfor A; The Pirbright Institute, Pirbright, Surrey, UK., Faralla C; AbCellera Biologics Inc, Vancouver, BC, Canada., Lam KJ; AbCellera Biologics Inc, Vancouver, BC, Canada., McComb R; AbCellera Biologics Inc, Vancouver, BC, Canada., Leifeld C; MSD Animal Health, Boxmeer, AN, The Netherlands., Pietersz K; MSD Animal Health, Boxmeer, AN, The Netherlands., King DP; The Pirbright Institute, Pirbright, Surrey, UK., van den Born E; MSD Animal Health, Boxmeer, AN, The Netherlands., Duncan SK; AbCellera Biologics Inc, Vancouver, BC, Canada., Charleston B; The Pirbright Institute, Pirbright, Surrey, UK., Fry EE; Division of Structural Biology, The Henry Wellcome Building for Genomic Medicine, University of Oxford, Headington, Oxford, UK., Ren J; Division of Structural Biology, The Henry Wellcome Building for Genomic Medicine, University of Oxford, Headington, Oxford, UK., Stuart DI; Division of Structural Biology, The Henry Wellcome Building for Genomic Medicine, University of Oxford, Headington, Oxford, UK. dave.stuart@strubi.ox.ac.uk.; Pandemic Sciences Institute, Nuffield Department of Medicine,, University of Oxford, Oxford, UK. dave.stuart@strubi.ox.ac.uk.; CAMS Oxford Institute, The Henry Wellcome Building for Genomic Medicine, University of Oxford, Headington, Oxford, UK. dave.stuart@strubi.ox.ac.uk., Hammond JA; The Pirbright Institute, Pirbright, Surrey, UK. john.hammond@pirbright.ac.uk.
Source: NPJ vaccines [NPJ Vaccines] 2026 Apr 02; Vol. 11 (1). Date of Electronic Publication: 2026 Apr 02.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-0105
DOI:10.1038/s41541-026-01427-7